Previous Article | Next Article 
Molecular and Cellular Biology, August 1999, p. 5405-5416, Vol. 19, No. 8
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Ssy1p and Ptr3p Are Plasma Membrane Components of a
Yeast System That Senses Extracellular Amino Acids
Hanna
Klasson,1
Gerald R.
Fink,2 and
Per O.
Ljungdahl1,*
Ludwig Institute for Cancer Research, S-171
77 Stockholm, Sweden1 and Whitehead
Institute for Biomedical Research, Cambridge, Massachusetts
021422
Received 4 January 1999/Returned for modification 22 February
1999/Accepted 4 May 1999
 |
ABSTRACT |
Mutations in SSY1 and PTR3 were identified
in a genetic selection for components required for the proper uptake
and compartmentalization of histidine in Saccharomyces
cerevisiae. Ssy1p is a unique member of the amino acid permease
gene family, and Ptr3p is predicted to be a hydrophilic protein that
lacks known functional homologs. Both Ssy1p and Ptr3p have previously
been implicated in relaying signals regarding the presence of
extracellular amino acids. We have found that ssy1 and
ptr3 mutants belong to the same epistasis group; single and
ssy1 ptr3 double-mutant strains exhibit indistinguishable phenotypes. Mutations in these genes cause the nitrogen-regulated general amino acid permease gene (GAP1) to be abnormally
expressed and block the nonspecific induction of arginase
(CAR1) and the peptide transporter (PTR2).
ssy1 and ptr3 mutations manifest identical differential effects on the functional expression of multiple specific
amino acid transporters. ssy1 and ptr3 mutants
have increased vacuolar pools of histidine and arginine and exhibit
altered cell growth morphologies accompanied by exaggerated invasive
growth. Subcellular fractionation experiments reveal that both Ssy1p
and Ptr3p are localized to the plasma membrane (PM). Ssy1p requires the
endoplasmic reticulum protein Shr3p, the amino acid permease-specific packaging chaperonin, to reach the PM, whereas Ptr3p does not. These
findings suggest that Ssy1p and Ptr3p function in the PM as components
of a sensor of extracellular amino acids.
 |
INTRODUCTION |
Amino acids are transported into the
yeast Saccharomyces cerevisiae by both general and specific
transport systems. These transport proteins are members of the
conserved amino acid permease (AAP) gene family that includes 18 members (3). The AAP genes are differentially
expressed. The nitrogen-regulated permeases, the general AAP
(GAP1 [34]), and the proline-specific
permease (PUT4 [63]) are high-capacity
systems that are induced by growth on low-quality nitrogen
sources, their expression enables cells to use amino acids as sole
nitrogen sources (14, 27, 45). The majority of other AAP
family members are low-capacity, high-affinity amino acid permeases,
each exhibiting characteristic narrow substrate specificities
(31). The transcriptional regulatory mechanisms governing
the expression of the low-capacity permeases are not well understood,
but in general their expression requires induction and appears less
dependent on nitrogen regulation (48). Despite different
modes of transcriptional regulation, the functional expression of AAPs
depends on the endoplasmic reticulum (ER) packaging chaperonin Shr3p.
In cells lacking SHR3, AAPs specifically accumulate in the
ER and are not transported to the plasma membrane (PM) (38,
43).
At least five proteins (Ure2p, Dal80p, Gln3p, Nil1p, and Nil2p)
function coordinately to control the transcription of many nitrogen-regulated genes, including GAP1 (9, 16, 59,
60). Dal80p, Gln3p, and Nil1p are DNA binding proteins that bind
to upstream regulatory sequences that contain a motif surrounding a core GATA sequence. Dal80p is a transcriptional repressor that competes with the transcriptional activators Gln3p and Nil1p for binding to GATA regulatory sequences (13, 15). In cells
grown in the presence of ammonium, Ure2p physically interacts with
Gln3p and prevents it from acting as an activator (6).
Similarly, when glutamine is present in the growth environment, Nil2p
represses NIL1 expression (55, 57). Thus, it is
only when both of these high-quality nitrogen sources are absent that
Gln3p and Nil1p are able to compete for binding to GATA regulatory
sequences and activate transcription. The mechanisms that independently
control or modulate Ure2p in response to ammonium and Nil2p activity in response to amino acids have not been elucidated.
In addition to regulation by GATA factors, the expression of many
nitrogen-regulated genes is controlled by both specific and nonspecific
induction mechanisms. For example, in cells grown in the presence
of arginine, arginase gene (CAR1) expression is greatly
induced. This specific induction is dependent on cis-acting sequences recognized by the Arg80p-Mcm1p activation complex
(18, 37). The ability of Arg80p-Mcm1p to induce
CAR1 expression is known to be controlled by intracellular
levels of arginine. CAR1 expression is nonspecifically
induced in cells grown in the presence of micromolar concentrations of
a variety of amino acids (19). The mechanisms controlling
the nonspecific induction of CAR1 have not been defined.
There is evidence that some members of the sugar and amino acid
transport gene families, though structurally similar to the transporters, act as nutritional sensors. For example, the hexose transporter (HXT) gene family is composed of more than 20 proteins related in sequence (3). Two unique members of this family, Snf3p and Rgt2p, control glucose uptake (41, 51a). These
proteins differ from other family members; they possess unusually long C-terminal domains, are poorly expressed compared to the other known
functional hexose transporters, and pleiotropically affect the function
of multiple HXTs. The C-terminal domain alone of Snf3p has been shown
to complement a number of snf3 mutant phenotypes, suggesting
that Snf3p does not function as an HXT but rather transduces nutritional signals regarding extracellular glucose availability (11).
The AAP gene family also contains a unique member, Ssy1p (32,
35), that differs from the other members of the family in that it
contains an unusually long N-terminal domain. The induced expression of a broad-specificity AAP gene (AGP1), several
specific branched-chain AAP genes (BAP2, TAT1,
and BAP3), and the peptide transporter gene
(PTR2) have been shown to require Ssy1p (17, 32).
The Ssy1p-dependent induction occurs in response to extracellular amino
acids and in the absence of detectable amino acid uptake (17,
32). In gap1 null mutant strains, ssy1
mutations pleiotropically affect the uptake of other, nonbranched amino
acids (17, 32). Based on its amino acid sequence and
similarity to known amino acid transporters, Ssy1p has been suggested
to act at the PM as a sensor of extracellular amino acids exhibiting
high sensitivity to hydrophobic amino acids, e.g., leucine (17,
32). In addition to Ssy1p, the induced expression of
PTR2 and BAP2 has been shown to be dependent on
Ptr3p (5). Ptr3p is predicted to be a hydrophilic protein
that lacks identifiable homologs of known function; these features have
made its localization and function less clear.
In this report, we describe the isolation and characterization of
mutations in SSY1 and PTR3 and demonstrate that
ptr3 mutant phenotypes are similar to those of
ssy1 despite differences in the structure, membrane
association, and intracellular trafficking of the two proteins.
ssy1
and ptr3
mutants exhibit altered
patterns of expression of two nitrogen-regulated genes, GAP1
and CAR1. In response to alternative nitrogen sources,
ssy1 and ptr3 mutations exert both negative and
positive effects on the transcription of a diverse spectrum of specific
amino acid and peptide transport proteins. Additionally,
ssy1
and ptr3
mutants have increased vacuolar pools of histidine and arginine and exhibit enhanced haploid-specific invasive growth. Subcellular fractionation experiments demonstrate that Ssy1p localizes to the PM in an Shr3p-dependent manner
and that Ptr3p is a peripheral membrane protein that localizes to the
cytosolic face of the PM. Our results suggest that Ssy1p and Ptr3p
function together at the PM, or within the same pathway, to transmit
signals regarding the availability of extracellular amino acids.
 |
MATERIALS AND METHODS |
Strains and media.
Yeast strains used are listed in Table
1. PLY2 was constructed from PLY1; the
mating type was switched by transformation with plasmid pGAL-HO
(29). PLY1 was transformed with a linear SalI/SpeI fragment of pHK030 (Table
2; plasmids are described below)
containing ssy1
12::hisG-URA3-hisG, and PLY2
was transformed with a linear EcoRI fragment of pPL341
containing ptr3
14::hisG-URA3-hisG; Ura+ transformants were propagated on medium containing
5-fluoroorotic acid (5-FOA) (28), resulting in strains HKY37
and HKY38, respectively. A spontaneous Ade+ revertant of
AA280 was isolated and crossed to AA288 (4), the resulting
diploid was sporulated, and tetrads were dissected. PLY122, PLY124, and
PLY125 are segregants from this cross. The diploid strain HKDY1,
obtained by mating PLY122 and PLY125, was transformed with the
ssy1
12::hisG-URA3-hisG cassette (pHK030). A
Ura+ transformant was sporulated, and tetrads were
dissected. ssy1
12 segregants were propagated on medium
containing 5-FOA to attain strains with the unmarked
ssy1
13 deletion (HKY20 and HKY21). A strain with the
unmarked ptr3
15 deletion (HKY31) was similarly constructed by using the
ptr3
14::hisG-URA3-hisG cassette (pPL341). The diploid strain HKDY5, obtained by mating HKY20 and HKY21, was used
to construct ssy1
13 ptr3
15 and ssy1
13
shr3
6 double-mutant strains. One allele of SHR3 in
HKDY5 was replaced with a linear SalI/EcoRI
fragment of pPL288 containing
shr3
5::hisG-URA3-hisG. After tetrad analysis,
an shr3
5 segregant was propagated on medium containing
5-FOA to attain HKY29. Similarly, one allele of PTR3 in
HKDY5 was replaced with ptr3
14 to create strain HKY33.
SHR3 in strain HKY31 was replaced, and the resulting
ptr3
15 shr3
5 double-mutant strain was propagated on
medium containing 5-FOA to create strain HKY51. Strain FGY58 is a
meiotic segregant from a diploid strain derived from the mating of
PLY129 with PLY214. ssy1
12 and ptr3
14
alleles were introduced directly into strain FGY58 by transformation,
resulting in strains HKY63 and HKY65, respectively. The
ptr3
14, ssy1
12, and shr3
5
alleles were introduced into the
1278b background strain 10480-5C to
create strains HKY39, HKY41, and HKY55. HKY40, HKY42, and HKY56 were
similarly derived from strain 10480-5D. HKY39 and HKY41 were propagated
on 5-FOA, resulting in strains HKY43 and HKY45, respectively. All gene
replacements were confirmed by Southern analysis. Diploid strains were
constructed by crossing strains as indicated in Table 1.
Standard yeast media were prepared as described in reference
28. Nonstandard synthetic media with alternative
nitrogen sources proline (SPD), leucine (SLD), glutamine (SQD),
glutamate (SED), and urea (SUD) were prepared as follows. The nitrogen
source (4 g/liter) and Difco Yeast Nitrogen Base (26.8 g/liter) were
combined to make 4× stock solutions that were filter sterilized. Other components were autoclaved as separate stock solutions (40% glucose, 4% Difco Bacto Agar). Stock solutions and sterile water were mixed to
make a 2× solution, and an equal volume of molten 4% agar was added.
Where required, SPD was supplemented with 30 mM L-histidine or 30 mM L-lysine. The concentration of Difco Yeast
Nitrogen Base in these synthetic media is fourfold higher than the
amount used in other standard synthetic media. Yeast transformations
were performed as described by Ito et al. (33), using 50 µg of heat-denatured calf thymus DNA. Transformants were selected on
solid synthetic complete (SC) dextrose medium lacking uracil.
Plasmids.
Plasmids and oligonucleotides used are listed in
Table 2. A 5-kb EcoRI fragment from pPL160 containing
PTR3 was inserted into EcoRI-digested pRS316
(56) to create pPL193. The 3.9-kb SpeI/ClaI fragment from pPL156 containing
SSY1 was inserted into SpeI/ClaI-digested pRS316 to create pPL356. The
ptr3
14 deletion cassette in pPL341 was constructed as
follows. The 5-kb EcoRI fragment in pPL193 was inserted into
the EcoRI site of a modified pUC118 (64) lacking
BamHI and HindIII endonuclease sites,
resulting in plasmid pPL334. Using single-stranded pPL334 as a
template, site-directed mutagenesis (oligonucleotide POL93-025) was
used to delete the entire PTR3 coding sequence and to
simultaneously create a unique BamHI site (pPL340)
(39). A 5-kb BglII/BamHI hisG-URA3-kanr-hisG cassette isolated from
pSE1076 (1) was inserted into the BamHI site of
pPL340 to create pPL341. pHK030 was constructed by inserting a
blunt-end 5-kb BglII/BamHI
hisG-URA3-kanr-hisG cassette into
BlpI/HindIII-digested pPL356 made blunt by treatment with Klenow fragment. This ssy1
construct
removes coding sequences for amino acids (aa) 95 to 783. A
hemagglutinin (HA) epitope-tagged version of SSY1 was
created in multiple steps. Plasmid pPL356 was digested with
EagI and SpeI, and the ends were made blunt by
treatment with Klenow enzyme and religated to form pHK002; this removed
the XbaI site in the polylinker. Site-directed single-stranded mutagenesis was used to remove an XbaI site
in SSY1 (oligonucleotide POL95-036) (pHK003) and to
introduce new XbaI-sites (oligonucleotides POL95-037,
POL95-038, and POL95-039) at the desired positions, creating pHK004,
pHK005, and pHK006. An XbaI-flanked cloning cassette,
encoding the HA epitope (66) reiterated three times
(HA3), was inserted into these unique XbaI sites
to form pHK010, pHK033, and pHK034. pHK013 was constructed by ligating
a KpnI/SacII fragment containing
SSY1-HA1 from pHK010 into
KpnI/SacII-digested pRS202 (10).
Similarly, the XbaI-flanked HA cloning cassette was inserted into a unique XbaI site (pHK024) previously introduced into
PTR3 (oligonucleotide POL96-045), creating plasmid pHK018.
The HA3 epitope is placed between amino acids 157 and 158 of Ptr3p.
Genetic analysis.
Strain PLY1 was used to isolate
spontaneous mutants resistant to 30 mM histidine (43). The
super-high-histidine-resistant (shr) mutants were
backcrossed to PLY4 (MAT
his4
29 ura3-52
ade2
1::URA3), an isogenic derivative of PLY1. Tetrad
analysis indicated that the mutant phenotypes segregated 2:2. Strains
PLAS7-4C (shr10-7), PLAS6-4D (shr6-6), and
PLAS14-1A (shr6-14) were obtained as meiotic segregants from
these crosses. SHR6 and SHR10 were cloned by
complementation of the 30 mM histidine-resistant phenotype exhibited by
strains PLAS14-1A (shr6-14) and PLAS7-4C
(shr10-7), respectively. These strains were transformed with
a plasmid library (54), and Ura+ transformants
unable to grow on selective media containing 30 mM histidine were
identified. The complementing plasmids were isolated and further
analyzed. Both strands of a 5-kb EcoRI fragment (pPL193)
that complemented all available shr6 alleles were sequenced and shown to contain a single complete open reading frame (ORF) (YFR029w). One strand of a 3.9-kb SpeI/ClaI
fragment (pPL356) that complemented all available shr10
alleles was sequenced and shown to contain one ORF (YDR160w).
Subcellular fractionation.
Cells expressing functional
epitope-tagged SSY1-HA1 and PTR3-HA1 were grown
in SC lacking uracil to an optical density at 600 nm
(OD600) of 0.8. Cells were harvested by centrifugation; protein extracts were prepared and fractionated on 12 to 60% sucrose gradients as described by Egner et al. (20). Fractions were collected from the bottom of the gradients by using a fraction recovery
system (Beckman). Proteins from equal aliquots of the collected
fractions were concentrated by trichloroacetic acid precipitation,
separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE), and blotted onto nitrocellulose membranes. Blots were
incubated for 2 h with primary antibody in blocking buffer diluted
as follows: 12CA5 ascites fluid (anti-HA monoclonal), 1:1,500; rabbit
anti-Dap2p, 1:2,000; rabbit anti-Pma1p, 1:3,000; rabbit anti-Wbp1p,
1:1,000; rabbit anti-Kex2p, 1:1,000. Blots were washed three times for
15 min each with washing buffer (phosphate-buffered saline, 0.1%
Tween-20), and incubated with horseradish peroxidase-coupled secondary
antibody, either anti-mouse (Amersham) or anti-rabbit (Jackson),
diluted 1:5,000 or 1:10,000 in washing buffer. Blots were washed three
times for 15 min each with washing buffer, and immunoreactive proteins
were visualized by chemiluminescence detection reagents (ECL or
ECL-PLUS Western blotting detection systems; Amersham).
Protein manipulations.
Protein was determined by the method
of Markwell et al. (47); whole-cell protein was determined
in lysates of cells boiled in 0.1 M NaOH. Ptr3p membrane association
was examined in whole-cell lysates prepared from strain HKY31
transformed with pHK018 grown in SC lacking uracil as described by
Chang and Slayman (7). Aliquots of lysate (100 µg of
protein) in low-salt BB buffer (0.3 M sorbitol, 5 mM MgCl2,
5 mM Tris [pH 7.5]) were diluted 1:1 with either H2O, 1.6 M urea, 0.6 M NaCl, 0.2 M Na2CO3 (pH 11.3), 2 mM EDTA, or low-salt BB buffer, mixed, and incubated on ice for 30 min.
Samples were centrifuged at 100,000 × g for 1 h
at 4°C, and protein pellets were resuspended in 2× sample buffer.
After sonication, denaturation, and incubation for either 10 min at 50°C or 3 min at 95°C, aliquots (10 µg of protein) were resolved by SDS-PAGE and analyzed by immunoblotting. To determine whether Ptr3p
is an intracellular protein, cells were grown in SC lacking uracil to
an OD600 of 0.8, harvested, washed once, resuspended in
spheroplasting buffer containing 10 mM NaN3 and 0.3 mg of
Zymolyase-100T per ml, and incubated at 30°C. Spheroplasts
(corresponding to 100 µg of protein) were placed on ice and treated
for 10 min with 0 to 100 µg of proteinase K per ml in the presence or
absence of 1% Triton X-100. Proteolysis was stopped by the addition of 2 mM phenylmethylsulfonyl fluoride (PMSF), and proteins resolved by
SDS-PAGE were analyzed by immunoblotting.
Amino acid uptake and pool size determination.
Cells were
grown in SUD containing uracil and histidine to an OD600 of
0.8, and amino acid uptake rates were assayed as described by Ljungdahl
et al. (43). The initial uptake rates were determined at
substrate concentrations of 10 and 0.004 mM; two
14C-labeled stock solutions (0.25 and 125 mCi
mmol
1) were used to obtain the desired final
concentrations. Citrulline uptake was measured at a substrate
concentration of 0.017 mM (57.8 mCi mmol
1) in cells grown
to an OD600 as described in the figure legends in either
YPD, SC, SQD, or SED. Subsamples were removed at 30, 90, and 180 s; the uptake rate for each amino acid and citrulline was linear
throughout the subsampling period. Uniformly 14C-labeled
L-amino acids and
L-ureido-14C]citrulline were
obtained from Amersham and NEN-Dupont, respectively. Whole-cell and
vacuolar amino acid pool concentrations were determined in cells grown
in YPD to an OD600 of
1 essentially as described by
Ohsumi et al. (51). Appropriate quantities of cultures
(3 × 108 cells) were harvested by centrifugation;
cell pellets were washed twice with 1.5 ml of water and resuspended in
1.5 ml of AA buffer (0.6 M sorbitol, 2.5 mM potassium phosphate buffer
[pH 6]) containing 10 mM glucose. For the determination of vacuolar
amino acid pools, the cells were resuspended in the same buffer
containing 0.8 mM CuCl2 and incubated 10 min at 30°C.
One-milliliter aliquots of cell suspensions were filtered (Whatman GF/F
filters), and filters were washed four times with AA buffer. The washed
filters were boiled in 3 ml of water for 15 min; 1-ml aliquots were
centrifuged to remove particles of filter. The concentrations of amino
acids in 30-µl aliquots were determined.
Northern analysis.
Strains PLY1, HKY37, and HKY38 were grown
to OD600 of 0.8 in SC, washed once with water, resuspended
in a 10× volume of YPD, SC, SD, SPD, SLD, SQD, SED, or SUD, and grown
to an OD600 of 0.8. Total RNA was prepared as described by
Elder et al. (21). Ten-microgram aliquots of denatured RNA
were separated by agarose electrophoresis using a formaldehyde buffer
system essentially as described in reference 46 and
transferred to a nylon membrane (Hybond-N+; Amersham) in 10× SSC (1×
SSC is 0.15 M NaCl plus 0.015 M sodium citrate). Blots were rinsed with
4× SSC and prehybridized for 5 h at 55°C in Church buffer (7%
SDS, 1% bovine serum albumin, 1 mM EDTA, 250 mM NaPi [pH
7.2]) (8). Radioactive probes were prepared as follows. An
800-bp EcoRI fragment of GAP1, excised from
pPL247 (43), and a 1.65-kb
BamHI/HindIII fragment containing ACT1 (50) were purified from agarose gels
(GELase; Amersham). The following DNA fragments were obtained by PCR
(the oligonucleotides used to prime the reactions are indicated in
parentheses; 25 ng of genomic DNA isolated from yeast strain S288C
served as the template): a 222-bp fragment from the N terminus of
DIP5 (POL97-038 and POL97-039), a 419-bp fragment from the
N-terminal region of GNP1 (POL97-042 and POL97-043), and a
569-bp fragment of CAR1 (POL98-012 and POL98-013). Twenty
nanograms of a plasmid genomic yeast DNA library was used as the
template for amplifying a 530-bp fragment from PTR2
(POL97-048 and POL97-049). PCR products were analyzed by restriction
analysis to ensure their identity and gel purified. DNA fragments were
labeled with [
-32P]dCTP (3,000 Ci/mmol; Amersham),
using a random-primed DNA labeling kit (MBI Fermentas Molecular
Biology). Hybridizations were carried out in Church buffer at 55°C
overnight (106 cpm/ml). Blots were rinsed once with 5×
SSC, washed twice for 20 min each time with 5× SSC, and washed twice
for 20 min each time with 0.5× SSC at 55°C. The amount of
radioactivity was quantitated with a Fujix BAS1500 bioimage analyzer
(Fuji Photo Film Co., Ltd., Tokyo, Japan). After background correction,
signal strengths were normalized to the levels of actin mRNA present in
RNA preparations.
Invasive growth assay.
Strains were patched on 1-day-old YPD
plates (2% agar) and incubated at 30°C. After 2 days of incubation,
plates were washed under a stream of running water as the surface
was gently rubbed with a finger to remove cells not in the agar, and
invasive growth was scored (24). Morphologies of invasive
cells were microscopically examined after growth on YPD for 5 days.
 |
RESULTS |
ssy1 and ptr3 mutations result in histidine
resistance.
Yeast strains carrying mutations in SHR6
and SHR10 were isolated in a genetic selection for
shr mutants resistant to 30 mM histidine (43) and
exhibit an identical level of resistance. SHR6 and
SHR10 were cloned by complementation of the 30 mM
histidine-resistant phenotype exhibited by strains PLAS14-1A
(shr6-14) and PLAS7-4C (shr10-7), respectively
(see Materials and Methods). Subsequent sequence analysis
indicated that SHR6 is identical to ORF YFR029w, also
known as PTR3 (5) and SSY3
(35), and SHR10 is identical to ORF YDR160w,
previously identified as SSY1 (35).
ssy1 and ptr3 null mutations are synthetic
lethal in combination with leu2.
Deletion alleles of
SSY1 and PTR3 were created by removal of protein
coding sequences and replacement of deleted segments with the
selectable marker URA3. These constructs,
ssy1
12::hisG-URA3-kanr-hisG and
ptr3
14::hisG-URA3-kanr-hisG,
were individually introduced into the diploid strain HKDY1 (HIS3/his3
200 LEU2/leu2-3,112 ura3-52/ura3-52
lys2
201/lys2
201) by transformation. Stable Ura+
transformants were selected and sporulated. Tetrads were dissected on
both YPD and synthetic minimal dextrose medium (SD; minimal medium
supplemented only with auxotrophic requirements). Spore viability was
excellent on SD medium. The URA3 marker segregated 2:2 and
in Leu+ spores was 100% linked to resistance to 30 mM histidine, showing that the deletion of either SSY1 or
PTR3 leads to a resistance phenotype. Spore-derived
colonies containing either ssy1
12 or ptr3
14
and the leu2 auxotrophic marker were not resistant to 30 mM
histidine and did not grow on YPD. The synthetic lethality of
ssy1
12 and ptr3
14 null mutations in
combination with the leu2 auxotrophic allele was reflected
in the pattern of spore inviability observed when tetrads were
dissected onto medium with high concentrations of all amino acids,
either YPD or SC.
A hallmark of mutations exhibiting pleiotropic effects on amino acid
transport is that they manifest synthetic lethality on complex media
when combined with mutations in genes encoding enzymes of amino acid
biosynthetic pathways (23, 35, 43, 49). We surmise that the
synthetic lethality on both YPD and SC is due to their high amino acid
content. On these media, the overabundance of competing amino
acids must interfere with the residual uptake mechanisms, effectively
inhibiting uptake of the required amino acid. Additionally, Gap1p in
cells grown on complex media is inactivated by posttranslational
mechanisms (58). Thus, when grown on either YPD or SC,
leu2 auxotrophic ssy1 or ptr3 mutants
cannot synthesize leucine, nor can they import leucine from the
external environment at rates sufficient to support growth.
SSY1 encodes a unique member of the AAP gene family
that localizes to the PM in an SHR3-dependent manner.
As previously shown (32, 35), SSY1 encodes a
unique member of the AAP gene family. Ssy1p is comprised of 852 aa,
whereas the other 17 members of AAP family average 604 (±24) aa in
length (range, 558 to 663). The sequence of Ssy1p is 22 to 28%
identical to those of the other AAP gene family members. The homology
between Ssy1p and the other AAPs begins with aa 278 of Ssy1p and
stretches throughout the remaining 574 aa. The function of this unique
N-terminal domain is not known.
We constructed HA3 epitope-tagged alleles of
SSY1 inserted in frame between aa 34 and 35 (ssy1-HA2), 68 and 69 (ssy1-HA3), and 206 and 207 (SSY1-HA1). Cell lysates prepared from
strain HKY20 individually transformed with CEN plasmid carrying these epitope-tagged constructs (pHK033, pHK034, and pHK010) expressed similar levels of HA-tagged proteins (data not shown). Although similar levels of HA-tagged proteins were detected, the
ssy1-HA2 and ssy1-HA3 tagged alleles did not
complement ssy1 mutations. The findings that in-frame
insertions within the extended N-terminal region abolish Ssy1p activity
without decreasing expressed protein levels suggest that the N-terminal
domain of Ssy1p is important for function. In contrast, the
SSY1-HA1 allele was judged functional based on its ability,
whether inserted into a low-copy (pHK010) or a multicopy 2µm (pHK013)
plasmid, to complement ssy1 mutant phenotypes. Specifically,
SSY1-HA1 complements the 30 mM histidine-resistant phenotype, sensitivity to 30 mM lysine, and the synthetic lethality in
combination with leu2 exhibited by ssy1 mutants.
The functional HA epitope-tagged allele of SSY1 was used to
monitor the subcellular fractionation of Ssy1p. Cell lysates were prepared from strain HKY20 carrying the CEN vector pHK010. The lysates
were fractionated on 12 to 60% step sucrose gradients (20).
Ssy1p-HA1 cofractionated with the PM marker protein, the plasma
membrane ATPase (Pma1p [Fig. 1A]),
indicating that Ssy1p is a component of the PM. Similar results were
obtained for SSY1-HA1 inserted into the 2µm plasmid
pHK013.

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 1.
Ssy1p is a component of the PM that requires the
AAP-specific packaging chaperone Shr3p to exit the ER. Cell lysates
from strains HKY20 (A) and HKY29 (shr3 6) (B) expressing a
functional HA epitope-tagged allele of SSY1 (pHK010) were
fractionated on 12 to 60% step sucrose gradients. Proteins within
fractions 1 to 11 were separated by SDS-PAGE and analyzed by
immunoblotting. The antibodies recognizing marker proteins Pma1p,
Wbp1p, Kex2p, and Dap2p were used to identify fractions containing PM,
ER, Golgi, and vacuolar proteins, respectively. Although most
membrane marker proteins reproducibly localized to specific fractions
in fractionation experiments, the location of the vacuolar marker
protein Dap2p occasionally varied in gradients; Dap2p localized to
lighter fractions (as in panel A) or more dense fractions (as in panel
B). The unpredictable behavior of Dap2p in gradients was not affected
by Shr3p function, and Dap2p localization did not correlate with
Ssy1p.
|
|
We examined whether the PM localization of Ssy1p was dependent on the
AAP-specific packaging chaperonin Shr3p (38, 43). A cell
lysate prepared from the shr3
6 ssy1
13 double-mutant
strain HKY29 transformed with pHK010 was fractionated on a 12 to 60% step sucrose gradient. In these lysates, the bulk of the
immunodetectable Ssy1p-HA1 was found in fractions 5 and 6, fractions
that contained the highest levels of the ER marker protein Wbp1p (Fig.
1B). Thus, Ssy1p behaves similarly to the other members of the AAP gene
family in that it requires Shr3p function for its localization to the PM.
Ptr3p is a peripheral membrane component of the PM.
The
PTR3 ORF encodes a protein of 678 aa with a calculated
molecular mass of 76.4 kDa (5). Ptr3p is predicted to be a
hydrophilic protein (Fig. 2A) that
contains a small region (aa 511 to 575) exhibiting protein sequence
homology to several AAPs and Gcn4p (Fig. 2B). Sequence similarities
were found by comparing the last 200 aa of Ptr3p with the
proteins in the yeast database, using the BLAST program
(2) and the PAM120 similarity matrix at the Saccharomyces genome database, Stanford University. In
pairwise comparisons using the Ptr3p sequence as the reference
sequence, protein similarities were found to be statistical significant (
5.5 standard deviations above the mean of 20 randomizations, using
the comparison algorithm BESTFIT in the Genetics Computer Group
Wisconsin Sequence Analysis Package). The homologous region of Gcn4p
(aa 129 to 180) lies between the two well-characterized transcriptional
activation (aa 107 to 125) and bZIP DNA binding (aa 226 to 281) domains
(22, 30). Each of the homologous regions within AAPs (see
Fig. 2 legend for amino acid coordinates) lies between putative
membrane-spanning domains 7 and 8 and is predicted to be on the
extracellular side of the PM.

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 2.
PTR3 encodes a peripheral component of the
PM. (A) Hydrophilicity plot of the predicted Ptr3p protein calculated
using a window size of 11 amino acid residues (40); (B)
Ptr3p shares protein sequence homology with Gcn4 and several members of
the AAP family. The sequence alignments between Ptr3p (aa 511 to 575),
the arginine permease (Can1p; aa 342 to 390), putative basic AAP
(Alp1p; aa 326 to 374), lysine permease (Lyp1p, aa 364 to 412),
branched-chain AAP (Bap2p; aa 346 to 395), valine/tyrosine permease
(Vap1p; aa 339 to 389), tryptophan permease (Tat2p; aa 325 to 372),
general AAP (Gap1p; aa 340 to 389), histidine permease (Hip1p; aa 340 to 390), and the general control regulatory protein Gcn4p (aa 129 to
180). The amino acid coordinates refer to amino acid residues in the
proteins from which they originate. Amino acid residues identical to
those in the Ptr3p sequence are indicated by white lettering on a black
background; identical amino acid residues found in at least four
sequences but not present in Ptr3p are highlighted with gray shading.
The membrane association of Ptr3p was examined in whole-cell
lysates prepared from strain HKY31 expressing PTR3-HA1 (C).
Aliquots of lysate were diluted 1:1 with H2O, 1.6 M urea,
0.6 M NaCl, 0.2 M Na2CO3 (pH 11.3), 2 mM EDTA,
or buffer containing 5 mM MgCl2, mixed, and incubated on
ice for 30 min. Membrane pellet (P) and soluble (S) fractions were
resolved by SDS-PAGE and analyzed by immunoblotting. As a control the
membrane association of the PM ATPase (Pma1p) was monitored. The
cellular localization of Ptr3p was determined by subcellular
fractionation (D). A cell lysate from strain HKY31 expressing
PTR3-HA1 was fractionated on a 12 to 60% step
sucrose gradient and analyzed as described in Fig. 1.
|
|
A functional epitope-tagged allele of PTR3
(PTR3-HA1) that complemented the 30 mM
histidine-resistant and 30 mM lysine-sensitive ptr3
mutant phenotypes was constructed. Cell lysates prepared from strain
HKY31 transformed with pHK018 (PTR3-HA1) were
fractionated. Although the predicted amino acid sequence of Ptr3p
is characteristic of a soluble hydrophilic protein, Ptr3p-HA1 clearly
fractionated as a membrane protein (Fig. 2C, lanes 1 to 3). We examined
the membrane association of Ptr3p by treating lysates with reagents known to extract peripherally associated membrane proteins. The results
(Fig. 2C, lanes 4 to 9) show that Ptr3p is extracted from membranes in
the presence of 0.1 M Na2CO3 (pH 11.3);
however, significant amounts of Ptr3p remain membrane associated in the presence of 0.8 M urea or 0.3 M NaCl, indicating that Ptr3p is a
tightly associated peripheral membrane protein. During the
subcellular fractionation experiments, we noticed that the
membrane association of Ptr3p was sensitive to EDTA. Incubation
of membrane preparations in the presence of 1 mM EDTA facilitated the
dissociation of Ptr3p (Fig. 2C, lanes 10 and 11); conversely, the
membrane association was stabilized in the presence of Mg2+
(Fig. 2C, lanes 12 and 13).
The intracellular location of Ptr3p was determined. A cell extract was
prepared from strain HKY31 expressing PTR3-HA1 (pHK018). The
prompt processing of the extract together with maintenance of high
protein concentrations in the extract stabilized the membrane interaction. The lysate was fractionated on a 12 to 60% step sucrose gradient. Ptr3p-HA1 cofractionated with Pma1p, the PM marker protein (Fig. 2D), indicating that Ptr3p is a component of the PM. In additional experiments, we found that Ptr3p localized to the PM in both
ssy1
and shr3
mutant strains (data not
shown), indicating that the primary targeting of Ptr3p to the PM is
independent of either Ssy1p or Shr3p function.
To determine whether Ptr3p was localized to the extra- or intracellular
side of the PM, spheroplasts prepared from strain HKY31 expressing
PTR3-HA1 were treated with proteinase K (data not shown). In
the absence of detergent, Ptr3p was refractory to protease treatment.
In the presence of 1% Triton X-100, the lowest concentration of
proteinase K (1 µg ml
1) degraded all of the
immunodetectable Ptr3p. These results suggest that Ptr3p is localized
to the cytosolic face of the PM. Consistent with these observations
Ptr3p lacks a recognizable signal sequence.
Mutations in SSY1 and PTR3 exhibit
pleiotropic effects on amino acid uptake.
Amino acid uptake into
isogenic wild-type and ptr3
15 and
ssy1
13 mutant cells was determined in strains
pregrown in SUD. Uptake rates were determined at low (4 µM) and high
(10 mM) substrate concentrations. The initial rates of uptake of four
representative amino acids are shown in Fig.
3, and a quantitative summary of the data
is presented in Table 3. At 4 µM
substrate (Fig. 3A), ptr3 and ssy1 mutations
exhibited a pleiotropic effect on several specific uptake systems. Most
notably, glutamate and phenylalanine uptake was reduced by 70% in
ptr3 and ssy1 mutants. Glutamate-specific transport is mediated by the dicarboxylic acid permease
(Dip5p [53]). The phenylalanine-specific
permease has not been defined. Reductions in the rates of histidine,
leucine, and lysine uptake were also observed (Table 3), indicating
that the histidine-specific permease (Hip1p [62]), the
branched-chain AAP (Bap2p [26]), and the
lysine-specific permease (Lyp1p [61]), respectively, are affected by mutations in SSY1 or PTR3. At 10 mM substrate (Fig. 3B; Table 3), the uptake of amino acids occurs
predominantly through Gap1p. ssy1 and ptr3
mutations reduce Gap1p activity by 50%. The rates of arginine uptake
were relatively unaffected by ssy1 and ptr3
mutations (Table 3).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 3.
Amino acid uptake into wild-type and
ssy1 13 and ptr3 15 null mutant strains.
Wild-type (PLY1; ), ssy1 13 (HKY37; ), and
ptr3 15 (HKY38; ) strains were grown in SUD containing
histidine and uracil. The uptakes of the indicated amino acids were
assayed as described in Materials and Methods. (A) High-affinity amino
acid uptake determined at amino acid concentrations of 4 µM; (B)
low-affinity amino acid uptake determined at amino acid concentrations
of 10 mM. Rate measurements were determined in duplicate samples; error
bars represent 1 standard deviation.
|
|
ssy1 and ptr3 mutations affect mRNA levels
of multiple genetically distinct AAPs and the peptide transporter
(PTR2).
We examined the steady-state mRNA levels of
GAP1, GNP1 (encoding glutamine permease
[67]), DIP5, and PTR2 (peptide
transporter gene [52]) in isogenic wild-type and
ssy1
13 and ptr3
15 mutant cells. Strains
grown in ammonium-containing SC were used to inoculate media containing
various nitrogen sources. The starting OD600 in each medium
was adjusted to 0.08, and RNA was isolated from cells when cultures
reached an OD600 of 0.8. Expression levels were analyzed by
Northern analysis. Under the growth conditions used, the mutations in
SSY1 and PTR3 did not adversely affect growth. In
all media except SED (see Fig. 6), wild-type and mutants strains
adjusted to the shift in nitrogen source similarly and grew at similar
rates. The levels of expression were quantitated by
phosphorimaging, and ACT1 transcript levels were used to
standardize quantitations. Regardless of the nitrogen source used in
the growth media, the levels of ACT1 transcripts per
OD260 of RNA were similar in RNA isolated from wild-type
and mutant cells. Results are presented in two formats: relative to the
levels of ACT1 mRNA (Fig. 4,
panels on left) and normalized to wild-type levels of expression (Fig. 4, panels on right).

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 4.
Mutations in SSY1 and PTR3 affect
the steady-state mRNA levels of multiple permeases. Total RNA isolated
from PLY1 (wild type [WT]), HKY37 (ssy1 ), and HKY38
(ptr3 ) was analyzed by Northern analysis. Expression
levels of GAP1 (A), DIP5 (B), GNP1
(C), and PTR2 (D) were determined in the strains grown to an
OD600 to 0.8 in media containing alternate nitrogen sources
as indicated. Signal strengths (arbitrary units) relative to the levels
of actin mRNA (ACT1) after background correction are plotted
in the panels to the left; mRNA levels normalized to the expression
observed in wild-type cells are replotted in the panels on the right.
|
|
When grown on YPD, SC, and SQD, ptr3 and ssy1
mutant strains expressed 4- to 15-fold higher levels of GAP1
mRNA than the isogenic wild-type strain (Fig. 4A). Conversely, when
grown on SD, SPD, and to a lesser extent SUD, mutant strains have lower
levels of GAP1 mRNA (Fig. 4A). Similarly, DIP5
expression in the mutants increased or decreased depending on the
nitrogen source (Fig. 4B). On SED, ssy1 and ptr3
mutants have two- to threefold more DIP5 mRNA than the
wild-type strain; on SPD, the mutants contain only 50% of the
wild-type DIP5 transcripts (Fig. 4B). In most instances, the
expression of GNP1 was found to depend on Ssy1p and Ptr3p
function. The wild-type strain had 2- to 18-fold higher levels of
GNP1 mRNA compared to either ssy1 or
ptr3 null mutant strains (Fig. 4C). GNP1 was
expressed in wild-type strains only when grown on media containing
amino acids; no significant GNP1 expression was observed on
SD lacking amino acids. The expression of PTR2 was also
found to be substantially reduced in mutant strains grown in YPD, SPD,
and SLD (Fig. 4D). Didion et al. (17) and Iraqui et al.
(32) have observed similar Ssy1p-dependent expression of
AGP1, BAP2, BAP3, TAT1, and
TAT2.
In summary, our data indicate that mutations in either SSY1
and PTR3 exert identical, direct or indirect effects on the
steady-state transcript levels of multiple permeases. Based on our
results and studies with gap1
ssy1
double-deletion
mutants (17, 32), the expression of at least a dozen
different, genetically distinct AAPs and the peptide transporter
(PTR2) appear to be affected by the combined function of
Ssy1p and Ptr3p.
Amino acid-dependent nonspecific induction of arginase
(CAR1) expression requires Ssy1p and Ptr3p.
We
examined D-leucine-stimulated L-leucine uptake,
peptide transporter (PTR2) expression, and arginase
(CAR1) expression in isogenic wild-type and ssy1
and ptr3 null mutant strains carrying a gap1 null
mutation (Fig. 5). FGY58 (wild type), HKY63 (ssy1
12), and
HKY65 (ptr3
14) were grown in ammonia-based SD containing uracil, lysine, and adenine to an OD600 of 1. Cells were
harvested, resuspended in fresh medium lacking or containing 0.15 mM
D-leucine, and incubated for 30 min at 30°C. As
previously described (5, 17), preincubation of wild-type
cells in the presence of D-leucine resulted in a twofold
stimulation of L-leucine uptake (Fig.
5A) and accumulation of PTR2
transcripts (Fig. 5B). Similarly, D-leucine induced a
twofold increase in the level of CAR1 transcripts in wild-type cells (Fig. 5C). In contrast to wild-type cells,
preincubation with D-leucine did not stimulate
L-leucine uptake or increase PTR2 or
CAR1 transcript levels in either ssy1 or
ptr3 mutant cells. These results provide the first
indication that cells may use Ssy1p- and Ptr3p-derived signals to
regulate the expression of non-transport-related genes. The
gap1 null mutant strains used in these experiments, although
unable to grow on citrulline as the sole nitrogen source, exhibited
substantial D-leucine uptake. Thus, we were unable to
determine whether the observed regulatory affects occurred in the
absence of D-leucine transport.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 5.
D-Leucine-stimulated transport and
nonspecific induction of arginase expression require Ssy1p and Ptr3p.
gap1 null mutant strains FGY58 (wild type [WT]), HKY63
(ssy1 ), and HKY65 (ptr3 ) were grown in SD
containing uracil, lysine, and adenine to an OD600 of 1. Cells were harvested and resuspended in fresh medium lacking or
containing 0.15 mM D-leucine (D-leu). After incubation for
30 min at 30°C, leucine uptake (A) and PTR2 (B) and
CAR1 (C) mRNA transcript levels were measured.
|
|
Physiological consequences of ptr3 and ssy1
mutations. (i)ssy1 and ptr3 mutants have
increased vacuolar pools of histidine and arginine.
The pool sizes
of amino acids were measured in whole cells and vacuoles in wild-type
(PLY1), ssy1 (PLAS7-4C), and ptr3 (PLAS6-4D and
PLAS14-1) strains (Fig. 6). In wild-type
cells, glutamate was the predominant amino acid, whereas in the mutant
strains, arginine was found to accumulate at the highest
concentrations. Arginine levels in both ssy1 and
ptr3 mutants were three- to fivefold higher than those in
the wild type (Table 4). Histidine levels were also higher (two- to fourfold), whereas lysine levels were unaffected (Table 4). In addition to the increased levels of histidine
and arginine, the mutant strains contained substantially higher
concentrations of serine, glutamine, glycine, and alanine. The levels
of other amino acids remained relatively unchanged.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 6.
Amino acid concentrations in whole cells and in vacuolar
pools of wild-type (PLAS1-7D), ssy1-107 (PLAS7-4C),
ptr3-66 (PLAS6-4D), and ptr3-614 (PLAS14-1A)
strains grown to a density of 2 × 107 cells/ml in
YPD. Whole-cell (A) and vacuolar (B) amino acid concentrations were
determined as described in Materials and Methods.
|
|
As expected, greater than 90% of the basic amino acids (arginine,
histidine, and lysine) were recovered in the vacuolar fraction (Fig.
6B). The acidic amino acids (aspartate and glutamate) were excluded
from the vacuole and maintained in cytosolic pools. The remaining amino
acids were found relatively evenly distributed between the cytosol and
vacuole. The intracellular distribution of amino acids that we observed
is consistent with previous studies (36). Our data indicate
that ssy1 and ptr3 mutations result in an
increased capacity to compartmentalize basic amino acids, but do not
affect the intracellular distribution of amino acids between the
vacuole and cytosol.
(ii) Growth on glutamate as sole nitrogen source.
We
examined the consequences of shifting wild-type (PLY1),
ptr3
15 (HKY38), and ssy1
13 (HKY37) cells
from media containing ammonia to media containing various amino
acids as sole nitrogen sources. A particularly striking effect was
observed when cells were shifted to SED (Fig.
7). Strains PLY1 (wild type), HKY38 (ptr3
) and HKY37 (ssy1
) were pregrown
in SC (OD600 of 0.8). Cells washed once with water were
used to inoculate fresh SC and SED to an OD600 of
0.15.
Wild-type and mutant strains grew at approximately the same rate
in SC (Fig. 7A). However, when shifted to glutamate (SED), the mutant
strains grew without substantial delay, whereas the wild-type
strain required a period of greater than 10 h before noticeable
growth was observed (Fig. 7B).

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 7.
Physiological consequences of ptr3 15 and
ssy1 13 null mutations. Strains PLY1 (wild type [WT]),
HKY37 (ssy1 ), and HKY38 (ptr3 ) were
pregrown in SC. Cells, washed once with water, were used to inoculate
either fresh SC (A) or SED (B); growth was monitored
spectrophotometrically (OD600). GAP1 mRNA levels
(C) and Gap1p activity (D) in cells shifted to SED were determined at
the times indicated.
|
|
Cells require a functional Gap1p to sustain high growth rates on media
containing amino acids as the predominant nitrogen sources (12,
36, 45, 65). It is known that although wild-type cells express
high levels of GAP1 mRNA in SED (compare GAP1
mRNA levels in Fig. 4A, left panel), Gap1p activity is maintained low, presumably posttranslational regulatory circuits maintain inactivate Gap1p (58). In our experiments, mutant strains growing on
SED initially had higher levels of GAP1 mRNA (mutant cells
have twofold more GAP1 mRNA [Fig. 7C, time zero) and
perhaps other nitrogen-regulated genes required for glutamate
utilization. Additionally, mutant strains more rapidly expressed
functionally active Gap1p (at 2 h, citrulline transport occurred
at rates sixfold greater than in wild-type cells [Fig. 7D]). Thus,
the absence of growth inhibition of mutant cells when shifted from
ammonium-based SC to SED correlates with increased levels of
GAP1 transcription and a concomitant increase in Gap1p activity.
(iii) ptr3 and ssy1 mutants exhibit
enhanced haploid invasive but not diploid pseudohyphal growth.
In
response to nutrient availability, growing yeast cells engage
distinct developmental pathways leading to vegetative growth or
filamentous-like growth. To examine whether Ssy1p- or Ptr3p-derived signals affect developmental outcomes, we constructed
1278b-derived ptr3 (HKY43) and ssy1
(HKY45) null mutant strains. The
1278b-derived mutants are
resistant to 30 mM histidine. When propagated on YPD, haploid
1278b-derived ptr3 (HKY43) and ssy1 (HKY45)
mutant strains exhibited enhanced invasive growth compared to an
isogenic wild-type strain (10480-5C) (Fig.
8A, upper sectors). The invasive growth was dependent on the
genetic background; ssy1 and
ptr3 strains in an S288C background did not invade the agar
(Fig. 8A, lower sectors). The invasive growth phenotype exhibited by
strains HKY43 and HKY45 was accompanied by changes in cell morphology.
Invasively growing cells were elongated and have an increased axial
(length/width) ratio. These elongated cells remained attached, leading
to the formation of filaments of cells (Fig. 8B). We quantitated this phenotype by taking photographs of cells remaining in the agar after
washing away surface growth. Cells present in areas of similar cell
densities were counted, and the number of cells with an axial ratio
greater than 2 was noted (Table 5). In
mutant strains, there was a >20-fold increase in the numbers of
elongated cells.

View larger version (75K):
[in this window]
[in a new window]
|
FIG. 8.
ssy1 and ptr3 mutants
exhibit enhanced haploid-specific invasive growth. (A) background strains 10480-5C (wild type [ WT]), HKY45
( ssy1 ), and HKY43 ( ptr3 ) and
S288C background strains PLY1 (WT), HKY37 (ssy1 ), and
HKY38 (ptr3 ) were patched on solid YPD and incubated for
2 days at 30°C. The plate was photographed before (total growth) and
after (invasive growth) cells were washed off the agar surface. (B) background strains (10480-5C, HKY45, and HKY43) were grown on solid YPD
incubated at 30°C for 5 days and invasively growing cells were
photographed. The 10-µm scale bar applies to all three photographs.
|
|
Homozygous shr3 diploid mutants exhibit extensive
pseudohyphal growth (25). We examined whether the
enhanced pseudohyphal growth exhibited by shr3 mutant
strains is due to decreased levels of Ssy1p (Fig. 1B) or Ptr3p in the
PM. Homozygous ssy1/ssy1 and ptr3/ptr3 diploid
mutant strains were constructed in the
background, these mutant
strains did not exhibit enhanced filamentous growth (data not shown).
Under similar conditions, extensive filamentous growth surrounding
colonies of a Shr3
diploid strain HKDY15 was observed.
These results indicate that the enhanced pseudohyphal growth exhibited
by shr3/shr3 strains is not a consequence of reduced PM
levels of Ssy1p or Ptr3p.
 |
DISCUSSION |
We have found that mutations in two genes, SSY1
(SHR10) and PTR3 (SHR6), cause the
nitrogen-regulated general AAP gene (GAP1) to be aberrantly
expressed and block the nonspecific induction of arginase
(CAR1). ssy1 and ptr3 mutations also
pleiotropically affect the steady-state levels of multiple specific
amino acid transporter mRNA transcripts and diminish the
expression of the peptide transporter (PTR2). Additionally,
ssy1
and ptr3
mutants have increased
vacuolar pools of histidine and arginine. The resistance of these
mutants to high concentrations of histidine is likely a consequence of
the altered uptake and increased capacity to compartmentalize
histidine. The observations that mutations in SSY1 and
PTR3 manifest identical phenotypes and ssy1
ptr3
double mutants do not exhibit additive effects suggest
that Ssy1p and Ptr3p function in the same pathway.
Our data extend previous work (5, 17, 32), suggesting that
Ssy1p and Ptr3p are components of an amino acid sensing system. The
assignment of Ssy1p and Ptr3p as components of an extracellular amino
acid sensor rests on a number of observations. First, mutations in
these genes, unlike those in the AAP genes, manifest identical
pleiotropic alterations in amino acid uptake (Fig. 3; Table 3) and
vacuolar amino acid pools (Fig. 6; Table 4). Second, although Ssy1p is
clearly a member of the AAP family and requires Shr3p to localize to
the PM (Fig. 1), it contains a functionally important N-terminal
extension absent from other family members. Third, the proper induction
of many AAPs requires Ssy1p and Ptr3p (Fig. 4 and 5) and occurs without
detectable amino acid uptake (17, 32). Our finding that
Ptr3p, which is not predicted to be a hydrophobic protein, fractionates
as a component of the PM (Fig. 2C and D) directly implicates this
protein as a constituent of this sensing system. As both Ssy1p and
Ptr3p are localized to the plasma membrane, they could interact,
although there is as yet no evidence for a physical association between them. According to this model (Fig. 9),
yeast cells use the PM Ssy1p/Ptr3p sensing system to regulate diverse
metabolic processes important for proper amino acid uptake and
compartmentalization, two processes that enable cells to maintain
cytosolic amino acid pools.
The localization of Ptr3p to the cytosolic face of the PM and the
observed sequence homology between Ptr3p and several AAPs and Gcn4p
(Fig. 2B) raises several possibilities. The homologous region within
Ptr3p may function as part of an amino acid binding site that regulates
Ptr3p activity. It is possible that Ssy1p transports regulatory amounts
of amino acids into the cell, and that this transport is coupled so
that amino acids are directed to this putative regulatory domain.
Alternatively, Ptr3p may function in sensing cytoplasmic levels of
amino acids, providing a regulatory loop that modulates the signals
generated by Ssy1p. Finally, we have found that under certain
conditions Ptr3p dissociates from the PM (Fig. 2C), thus the
possibility exists that the regulatory events controlled by the
Ssy1p/Ptr3p sensor require that Ptr3p disengage from the membrane.
After activation, presumably the consequence of a Ssy1p-dependent
event, regulatory amounts Ptr3p could localize to other regions of the
cell to directly exert a controlling function.
ssy1 and ptr3 mutants express elevated
levels of GAP1 mRNA (Fig. 4A) when grown on amino acid-rich
medium (either YPD or SC) and in medium containing glutamine as
the sole nitrogen source (SQD). These results indicate that Ssy1p/Ptr3p
are part of a pathway that can negatively regulate GAP1
expression. Two pathways converge to control nitrogen-regulated genes,
one sensitive to the presence of ammonium (Ure2p and Gln3p) and the
other sensitive to the presence of amino acids (Nil2p and Nil1p)
(6, 55, 57). Regulation by Ssy1p/Ptr3p-derived signals is
independent of ammonia repression: ssy1/ptr3 mutants grown
in SD without amino acids but the same level of ammonia as SC express
similar levels of GAP1 as wild-type cells (Fig. 4A). As the
expression pattern of Gap1p in ssy1 and ptr3
mutants mimics that found in a strain lacking the Nil2p repressor (55), the Ssy1p/Ptr3p-derived signals may be mediated
through the Nil2p/Nil1p pathway.
The observation that haploid ssy1 and ptr3
strains exhibit enhanced invasive growth is consistent with these
proteins being components of an amino acid sensor. Presumably, the
enhanced invasiveness is a consequence of the erroneous sensing in
mutant cells of the availability of amino acids in the extracellular
environment. Our findings suggest that wild-type cells use Ssy1p-
and Ptr3p-derived signals to moderate invasive growth. Similarly,
the high-affinity ammonium permease (MEP2) is thought
to act as an ammonium sensor that influences the frequency at which
diploid cells enter the pseudohyphal growth pathway (44).
The observation that nutrient sensors acting at the PM are required to
initiate proper growth responses raises the possibility that yeast
cells do not rely solely on intracellularly derived nutritional signals
for making decisions affecting developmental outcomes.
 |
ACKNOWLEDGMENTS |
We thank Tom Stevens, Robert Fuller, Carolyn Slayman, and Stephan
te Heesen for their generous gifts of antibodies to Dap2p, Kex2p,
Pma1p, and Wbp1p, respectively. We thank C. Fredrik Gilstring for
S. cerevisiae FGY58 and members of Ljungdahl laboratory for constructive comments, especially Marten Hammar for critical review of
the manuscript.
This work was supported by NIH grants GM40266 and GM35010 (G. R. Fink) and the Ludwig Institute for Cancer Research (P. O. Ljungdahl).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Ludwig Institute
for Cancer Research, Box 240, S-171 77 Stockholm, Sweden. Phone: 46 8 728 7108. Fax: 46 8 33 28 12. E-mail: plju{at}licr.ki.se.
 |
REFERENCES |
| 1.
|
Allen, J. B., and S. J. Elledge.
1994.
A family of vectors that facilitate transposon and insertional mutagenesis of cloned genes in yeast.
Yeast
10:1267-1272[Medline].
|
| 2.
|
Altschul, S. F.,
W. Gish,
W. Miller,
E. W. Myers, and D. J. Lipman.
1990.
Basic local alignment search tool.
J. Mol. Biol.
215:403-410[Medline].
|
| 3.
|
André, B.
1995.
An overview of membrane transport proteins in Saccharomyces cerevisiae.
Yeast
11:1575-1611[Medline].
|
| 4.
|
Antebi, A., and G. R. Fink.
1992.
The yeast Ca2+-ATPase homologue, PMR1, is required for normal Golgi function and localizes in a novel Golgi-like distribution.
Mol. Biol. Cell
3:633-654[Abstract].
|
| 5.
|
Barnes, D.,
W. Lai,
M. Breslav,
F. Naider, and J. M. Becker.
1998.
PTR3, a novel gene mediating amino acid-inducible regulation of peptide transport in Saccharomyces cerevisiae.
Mol. Microbiol.
29:297-310[Medline].
|
| 6.
|
Blinder, D.,
P. W. Coschigano, and B. Magasanik.
1996.
Interaction of the GATA factor Gln3p with the nitrogen regulator Ure2p in Saccharomyces cerevisiae.
J. Bacteriol.
178:4734-4736[Abstract/Free Full Text].
|
| 7.
|
Chang, A., and C. W. Slayman.
1991.
Maturation of the yeast plasma membrane [H+]ATPase involves phosphorylation during intracellular transport.
J. Cell Biol.
115:289-295[Abstract/Free Full Text].
|
| 8.
|
Church, G. M., and W. Gilbert.
1984.
Genomic sequencing.
Proc. Natl. Acad. Sci. USA
81:1991-1995[Abstract/Free Full Text].
|
| 9.
|
Coffman, J. A.,
R. Rai,
D. M. Loprete,
T. Cunningham,
V. Svetlov, and T. G. Cooper.
1997.
Cross regulation of four GATA factors that control nitrogen catabolic gene expression in Saccharomyces cerevisiae.
J. Bacteriol.
179:3416-3429[Abstract/Free Full Text].
|
| 10.
|
Connelly, C., and P. Hieter.
1996.
Budding yeast SKP1 encodes an evolutionarily conserved kinetichore protein required for cell cycle progression.
Cell
86:275-285[Medline].
|
| 11.
|
Coons, D. M.,
P. Vagnoli, and L. F. Bisson.
1997.
The C-terminal domain of Snf3p is sufficient to complement the growth defect of snf3 null mutations in Saccharomyces cerevisiae: SNF3 functions in glucose recognition.
Yeast
13:9-20[Medline].
|
| 12.
|
Cooper, T.
1982.
Transport in Saccharomyces cerevisiae, p. 399-461.
In
J. N. Strathern, E. W. Jones, and J. R. Broach (ed.), The molecular biology of the yeast Saccharomyces: metabolism and gene expression. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 13.
|
Coornaert, D.,
S. Vissers,
B. André, and M. Grenson.
1992.
The UGA43 negative regulatory gene of Saccharomyces cerevisiae contains both a GATA-1 type zinc finger and a putative leucine zipper.
Curr. Genet.
21:301-307[Medline].
|
| 14.
|
Courchesne, W. E., and B. Magasanik.
1983.
Ammonia regulation of amino acid permeases in Saccharomyces cerevisiae.
Mol. Cell. Biol.
3:672-683[Abstract/Free Full Text].
|
| 15.
|
Cunningham, T. S., and T. G. Cooper.
1993.
The Saccharomyces cerevisiae DAL80 repressor protein binds to multiple copies of GATAA-containing sequences (URSGATA).
J. Bacteriol.
175:5851-5861[Abstract/Free Full Text].
|
| 16.
|
Daugherty, J. R.,
R. Rai,
H. M. Berry, and T. G. Cooper.
1993.
Regulatory circuit for response of nitrogen catabolic gene expression to the GLN3 and DAL80 proteins and nitrogen catabolic repression in Saccharomyces cerevisiae.
J. Bacteriol.
175:64-73[Abstract/Free Full Text].
|
| 17.
|
Didion, T.,
B. Regenberg,
M. U. Jørgensen,
M. C. Kielland-Brandt, and H. A. Andersen.
1998.
The permease homologue Ssy1p controls the expression of amino acid and peptide transporter genes in Saccharomyces cerevisiae.
Mol. Microbiol.
27:643-650[Medline].
|
| 18.
|
Dubois, E., and F. Messenguy.
1997.
Integration of the multiple controls regulating the expression of the arginase gene CAR1 of Saccharomyces cerevisiae in response to different nitrogen signals: role of Gln3p, ArgRp-Mcm1p, and Ume6p.
Mol. Gen. Genet.
253:568-580[Medline].
|
| 19.
|
Dubois, E. L., and J.-M. Wiame.
1976.
Non specific induction of arginase in Saccharomyces cerevisiae.
Biochimie
58:207-211[Medline].
|
| 20.
|
Egner, R.,
Y. Mahé,
R. Pandjaitan, and K. Kuchler.
1995.
Endocytosis and vacuolar degradation of the plasma membrane-localized Pdr5 ATP-binding cassette multidrug transporter in Saccharomyces cerevisiae.
Mol. Cell. Biol.
15:5879-5887[Abstract].
|
| 21.
|
Elder, R. T.,
E. Y. Loh, and R. W. Davis.
1983.
RNA from the yeast transposable element TY1 has both ends in the direct repeats, a structure similar to retrovirus RNA.
Proc. Natl. Acad. Sci. USA
80:2432-2436[Abstract/Free Full Text].
|
| 22.
|
Ellenberger, T. E.,
C. J. Brandl,
K. Struhl, and S. C. Harrison.
1992.
The GCN4 basic region leucine zipper binds DNA as a dimer of uninterrupted helices: a crystal structure of the protein-DNA complex.
Cell
71:1223-1237[Medline].
|
| 23.
|
Garrett, J. M.
1989.
Characterization of AAT1: a gene involved in the regulation of amino acid transport in Saccharomyces cerevisiae.
J. Gen. Microbiol.
135:2429-2437 |